Company secures funding to fuel expansion of its Thoraguard® System; adds veteran medtech leader Timothy Still to Board of Directors
Centese, Inc., a leader in digital surgery technology, announces the successful closing of its $15M Series B funding round. The round, led by Medical Technology Venture Partners with participation from new and existing investors, will fund commercialization efforts, advance clinical initiatives, and bolster advanced product development of the Thoraguard Intelligent Chest Tube Management System.
“This Series B funding marks an exciting milestone for Centese,” said Evan Luxon, CEO of Centese, Inc. “This investment not only validates the rapid adoption of digital technology in surgery but will accelerate our mission to transform the recovery process for as many heart and lung surgery patients as possible.”
The Thoraguard…